Related Experiment Video
Updated: Jun 12, 2026
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Effects of Di(2-ethylhexyl) phthalate (DEHP) and hyperoxia on cardiovascular development in newborn rats
Fatima Toor1,2, Mane Sargsyan3,4, Abigail Akselrod3,5
1Northwell Health, New Hyde Park, New York, NY, USA. fatima.t.toor@gmail.com.
Insights
Neonatal exposure to DEHP and hyperoxia harms cardiovascular development. This study reveals DEHP
Area of Science:
- Neonatal physiology
- Environmental toxicology
- Cardiovascular research
Background:
- Preterm infants face DEHP exposure via medical devices.
- Hyperoxia is known to cause cardiac dysfunction.
- Early phthalate exposure's cardiovascular impact is understudied.
Purpose of the Study:
- To investigate the effects of DEHP and hyperoxia on neonatal cardiovascular development.
- To determine if combined exposure exacerbates cardiac impairments.
- To identify specific molecular markers affected by these exposures.
Main Methods:
- Newborn rats exposed to control, hyperoxia, DEHP, or combined conditions (birth-day 14).
- Cardiac tissue and serum analyzed via histology, RT-qPCR, and ELISA.
- Assessed markers of contractility (Myh6), angiogenesis (VEGF), and inflammation (IL-4, IL-10, CX3CL1).
Main Results:
- All exposures increased cardiac cell size and nuclear area.
- DEHP and hyperoxia reduced Myh6 and VEGF gene expression.
- DEHP + hyperoxia elevated serum VEGF and CX3CL1, while decreasing IL-4 and IL-10.
Conclusions:
- DEHP and hyperoxia independently and concurrently disrupt neonatal cardiac morphology, contractility, angiogenesis, and inflammation.
- DEHP is identified as a modifiable contributor to adverse cardiovascular development in neonates.
- Findings suggest a novel approach to study environmental toxins' role in newborn cardiovascular disease.
Background:
Preterm infants encounter DEHP through medical devices and equipment. While hyperoxia is known to promote cardiac remodeling and dysfunction, the impact of early phthalate exposure is understudied. We hypothesized that independent and combined DEHP and hyperoxia exposure would impair neonatal cardiovascular development.
Methods:
Newborn rats were exposed from birth to day 14 to one of four conditions: control (21% oxygen), hyperoxia (60% oxygen), DEHP (25 mg/m3), and DEHP + hyperoxia (25 mg/m3 DEHP and 60% oxygen). Cardiac tissue and serum were analyzed by histology, RT-qPCR and ELISA for markers of contractility, angiogenesis, and inflammation: myosin heavy chain 6 (Myh6), vascular endothelial growth factor (VEGF), interleukin-4 (IL-4), interleukin-10 (IL-10), and fractalkine (CX3CL1).
Results:
Histology found increased cell size, cytoplasm per nucleus, and nuclear area in all exposures. DEHP exposure and hyperoxia exposure reduced Myh6 and VEGF gene expression. Serum VEGF was higher in the DEHP + hyperoxia group compared to hyperoxia alone. IL-10 was decreased in all exposed groups. IL-4 was reduced in the DEHP + hyperoxia group. CXC3L1 was increased in the DEHP + hyperoxia group compared to hyperoxia alone.
Conclusion(S):
Independent and concurrent DEHP and hyperoxia exposure during early neonatal development significantly disrupted markers of cardiac morphology, contractility, angiogenesis, and inflammation.
Impact:
Key Message: Postnatal exposure to DEHP adversely impacts neonatal rat cardiovascular development. Adds to Existing Literature: This is the first study to examine concurrent long-term hyperoxia and DEHP exposure on cardiovascular development in an animal model relevant to preterm infants. Identifies a modifiable contributor, DEHP, to adverse cardiovascular development. Identifies various cardiovascular components affected by DEHP and hyperoxia, including structural, angiogenic, contractile, and inflammatory aspects. Leads to a new approach to investigate the impact of environmental toxins and the origin of cardiovascular disease in the newborn period.